Sigal Fishman

Research output

Research output per year 1999 2001 2002 2010 2013 2014 2017 2021 2023 2025

• 62 Article
• 3 Comment/debate
• 3 Letter

Research output per year

Research output per year

Search results

• 2023

  Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

  Ryder, R. E. J., Laubner, K., Benes, M., Haluzik, M., Munro, L., Frydenberg, H., Teare, J. P., Ruban, A., Fishman, S., Santo, E., Stengel, R., De Jonge, C., Greve, J. W., Cohen, R. V., Aboud, C. M., Holtmann, G. J., Rich, G., McMaster, J. J., Battelino, T. & Kotnik, P. & 18 others, Byrne, J. P., Mason, J. C., Bessell, J., Bascomb, J., Kow, L., Collins, J., Chisholm, J., Pferschy, P. N., Sourij, H., Cull, M. L., Wyres, M. C., Drummond, R., McGowan, B., Amiel, S. A., Yadagiri, M., Gupta, P. S., Aberle, J. & Seufert, J., Apr 2023, In: Diabetes Care. 46, 4, p. e89-e91

  Research output: Contribution to journal › Letter › peer-review
  11 Scopus citations
• 2021

  Eculizumab-Responsive Adult Onset Protein Losing Enteropathy, Caused by Germline CD55-Deficiency and Complicated by Aggressive Angiosarcoma

  Hagin, D., Lahav, D., Freund, T., Shamai, S., Brazowski, E., Fishman, S., Kurolap, A., Baris Feldman, H., Shohat, M. & Salomon, O., Feb 2021, In: Journal of Clinical Immunology. 41, 2, p. 477-481 5 p.

  Research output: Contribution to journal › Letter › peer-review
  8 Scopus citations
• 2013

  Reply to: "Direct actions of GLP-1 analogues on AMP-activated protein kinase activity are distinct from cyclic AMP accumulation"

  Fishman, S. & Zvibel, I., Mar 2013, In: Journal of Hepatology. 58, 3, p. 635-636 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access